D. Reker

Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria.

M. Karsdal, A. Mobasheri, Y. Henrotin, 2016, Osteoarthritis and cartilage.

Sprifermin (rhFGF18) versus vehicle induces a biphasic process of extracellular matrix remodeling in human knee OA articular cartilage ex vivo

M. Karsdal, A. Gigout, C. Ladel, 2020, Scientific Reports.

A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation

M. Karsdal, A. Mobasheri, O. Simonsen, 2018, International journal of molecular sciences.

Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo

M. Karsdal, A. Gigout, C. Ladel, 2017, Journal of Translational Medicine.

Sprifermin (rhFGF18) enables proliferation of chondrocytes producing a hyaline cartilage matrix.

M. Karsdal, A. Gigout, C. Ladel, 2017, Osteoarthritis and cartilage.

MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.

C. Hother, C. Workman, K. Grønbæk, 2013, Investigative ophthalmology & visual science.

Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model

M. Karsdal, K. Henriksen, D. Reker, 2021, Menopause.